In 2019, the digital economy has become an important driving force for global economic growth. The pharmaceutical industry is an important part of China's national economy. At the same time, China is also the world's largest producer and exporter of APIs, and it is also a major informatization application, although it is a drug. The transformation of enterprises has already begun to sail, but the road to transformation is still "a long way to go." With the high-frequency iteration of the new generation of ICT technology, the entire pharmaceutical industry is facing enormous challenges, but at the same time it is accompanied by subversive opportunities. Where is the digital transformation of pharmaceutical companies?
In order to better cope with the trend of digital transformation, the reconstruction of organizational digital capabilities is the top priority for digital transformation! How should the organization reconstruct its digital capabilities and move forward steadily in the informatization wave to be the future?
In response to this trend, PCS 2019 is based on the theme of “Reconstructing Organizational Digital Capabilities and Opening a New Era of Digital Medicine”. It gathers industry giants to deeply reveal cloud computing , big data , artificial intelligence, blockchain, 5G, IOT, and mobile internet. Such as the practical application of a new generation of information technology in the pharmaceutical industry, a comprehensive understanding of the information development of the pharmaceutical industry, and the industry leader to win the future of digital transformation!